Propylthiouracil

丙硫氧嘧啶

Report date: 2026/04/16 20:00:17
NME

Base Information

Drug NamePropylthiouracil
Drug Alias Name丙基硫氧嘧啶propiltiouracilopropylthiouracile丙基硫尿嘧啶propylthiouracilum +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThyroid peroxidase inhibitors
TargetsThyroid peroxidase
Therapy Area/IndicationsHyperthyroidism
Global Approved IndicationsHyperthyroidism
Approved Indications in ChinaHyperthyroidism
Original Approved Country/TerritoryCanada
Original Approved Date1945/12/31
Country/TerritoryCanadaUnited StatesUnited Kingdom +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesPH Health LtdWockhardt Uk LtdTakeda Pharmaceutical Co Ltd +[7] 
Inactive CompaniesPaladin Labs Inc
Active IndicationsHyperthyroidism
Inactive IndicationsN/A

Other Information

ATC CodeH03BA02
Related LinksWikipediaDrugBankKEGG